Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biosyent Inc (TSE:RX)
TSXV:RX
Biosyent (RX) Stock Price & Analysis
35 Followers
RX Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$6.93 - C$9.21
Previous CloseC$8.55
Volume1.78K
Average Volume (3M)5.22K
Market Cap
C$102.14M
Enterprise ValueC$74.11M
Total Cash (Recent Filing)C$29.29M
Total Debt (Recent Filing)C$1.27M
Price to Earnings (P/E)16.0
Beta0.37
Next Earnings
May 30, 2024EPS Estimate
C$0.08Last Dividend Ex-Date
Feb 28, 2024Dividend Yield1.91%
Share Statistics
EPS (TTM)0.54
Shares Outstanding11,824,618
10 Day Avg. Volume7,209
30 Day Avg. Volume5,224
Standard Deviation0.09
R-Squared0.23
Alpha0.00067
Financial Highlights & Ratios
Price to Book (P/B)3.06
Price to Sales (P/S)3.61
Price to Cash Flow (P/CF)10.60
P/FCF Ratio10.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Biosyent News
PremiumCompany Announcements
BioSyent Secures Rights Extension for Key Products
PremiumCompany Announcements
BioSyent Inc. Spotlights at Investor Conference
PremiumCompany Announcements
FeraMAX Maintains Top Spot in Canadian Iron Supplements
PremiumCompany Announcements
BioSyent CEO to Speak at Investor Conference
PremiumCompany Announcements
BioSyent Awards Stock to Key Team MembersOptions Prices
Currently, No data available
---
Ownership Overview
52.15% Insiders
0.41% Mutual Funds
<0.01% Other Institutional Investors
47.45% Public Companies and
Individual Investors
RX FAQ
What was Biosyent Inc’s price range in the past 12 months?
Biosyent Inc lowest stock price was C$6.92 and its highest was C$9.21 in the past 12 months.
What is Biosyent Inc’s market cap?
Currently, no data Available
When is Biosyent Inc’s upcoming earnings report date?
Biosyent Inc’s upcoming earnings report date is May 30, 2024 which is in 40 days.
How were Biosyent Inc’s earnings last quarter?
Biosyent Inc released its earnings results on Mar 13, 2024. The company reported C$0.12 earnings per share for the quarter, missing the consensus estimate of C$0.17 by -C$0.05.
Is Biosyent Inc overvalued?
According to Wall Street analysts Biosyent Inc’s price is currently Overvalued.
Does Biosyent Inc pay dividends?
Biosyent Inc pays a Quarterly dividend of C$0.04 which represents an annual dividend yield of 1.91%. See more information on Biosyent Inc dividends here
What is Biosyent Inc’s EPS estimate?
Biosyent Inc’s EPS estimate is C$0.08.
How many shares outstanding does Biosyent Inc have?
Biosyent Inc has 11,821,561 shares outstanding.
What happened to Biosyent Inc’s price movement after its last earnings report?
Biosyent Inc reported an EPS of C$0.12 in its last earnings report, missing expectations of C$0.17. Following the earnings report the stock price went down -0.462%.
Which hedge fund is a major shareholder of Biosyent Inc?
Currently, no hedge funds are holding shares in TSE:RX
---
Biosyent Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth C$7.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
15.58%
12-Months-Change
Fundamentals
Return on Equity
18.97%
Trailing 12-Months
Asset Growth
2.58%
Trailing 12-Months
Company Description
Biosyent Inc
Biosyent Inc is a specialty pharmaceutical company engaged in developing pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System and Cysview. The company through its subsidiaries sources acquires or in-licenses pharmaceutical products and markets the products. Geographically all the activities are functioned through the region of Canada.
---
RX Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering RX
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+6.50%
reiterated a buy rating 5 months ago
Copying David Martin PhD's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +6.50% per trade.
---